newsfilter
← Latest News
Earnings Call Transcripts·

CERENOME (NASDAQ: CNSY) REBRAND, FORMERLY PLUS THERAPEUTICS | FINTECH TV EXCLUSIVE - CERENOME INC

Serenome, formerly known as Plus Therapeutics, is rebranding as it moves from single drug developer to a full CNS cancer platform, combining therapeutics, diagnostics, and AI. The new ticker is CNSY, and it takes effect

Company
CERENOME INC
Keywords
CERENOME INC